Latest news
NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome - TheNewswireTheNewswire · Wed, 05 Aug 2026 12:09:29 GMTNeuroThera starts Phase IIb trial of SCI-110 fo... - PluangPluang · Wed, 05 Aug 2026 07:00:00 GMTNeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company - tradingview.comtradingview.com · Wed, 29 Jul 2026 12:05:03 GMT